MARCHIONI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 7.219
AS - Asia 4.213
EU - Europa 3.317
SA - Sud America 564
AF - Africa 95
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 15.432
Nazione #
US - Stati Uniti d'America 7.041
SG - Singapore 2.256
CN - Cina 831
IT - Italia 784
IE - Irlanda 609
RU - Federazione Russa 586
VN - Vietnam 445
BR - Brasile 439
SE - Svezia 328
DE - Germania 310
GB - Regno Unito 151
BD - Bangladesh 121
HK - Hong Kong 120
IN - India 119
UA - Ucraina 109
FI - Finlandia 99
CA - Canada 87
TR - Turchia 86
MX - Messico 61
AR - Argentina 55
JP - Giappone 51
FR - Francia 42
NL - Olanda 42
ES - Italia 37
PL - Polonia 37
AT - Austria 35
ZA - Sudafrica 34
CZ - Repubblica Ceca 25
IQ - Iraq 25
EC - Ecuador 22
PK - Pakistan 22
BE - Belgio 21
MA - Marocco 21
SA - Arabia Saudita 20
LT - Lituania 17
CH - Svizzera 11
ID - Indonesia 11
KR - Corea 11
PH - Filippine 11
UZ - Uzbekistan 11
HR - Croazia 10
IL - Israele 10
VE - Venezuela 10
CL - Cile 9
EE - Estonia 9
JO - Giordania 9
AU - Australia 8
BG - Bulgaria 8
CO - Colombia 8
DZ - Algeria 8
EG - Egitto 8
AZ - Azerbaigian 7
HU - Ungheria 7
MY - Malesia 7
PY - Paraguay 7
KE - Kenya 6
NP - Nepal 6
PE - Perù 6
RO - Romania 6
IR - Iran 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
BO - Bolivia 4
EU - Europa 4
HN - Honduras 4
JM - Giamaica 4
ME - Montenegro 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
ET - Etiopia 3
NO - Norvegia 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GD - Grenada 2
GL - Groenlandia 2
GR - Grecia 2
GT - Guatemala 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
Totale 15.406
Città #
Singapore 1.724
San Jose 940
Chandler 900
Ashburn 726
Dublin 598
Dallas 469
Jacksonville 315
Beijing 308
Princeton 285
Los Angeles 227
Santa Clara 164
Munich 157
The Dalles 147
Ho Chi Minh City 144
Council Bluffs 134
Altamura 131
New York 120
Boardman 109
Wilmington 107
Hanoi 105
Hong Kong 105
Chieti 102
Pescara 87
Buffalo 77
Washington 65
Helsinki 63
Redondo Beach 59
Izmir 58
Moscow 58
Orem 56
Seattle 51
Ann Arbor 47
Tokyo 46
São Paulo 43
Dearborn 39
London 39
Nanjing 39
Woodbridge 39
Hefei 38
Falls Church 37
Frankfurt am Main 35
Brooklyn 33
Rome 33
Warsaw 33
Tongling 32
Atlanta 31
Nuremberg 31
Houston 29
Montreal 29
Stockholm 28
Milan 27
Fairfield 26
Dong Ket 25
Mexico City 25
Chicago 24
Toronto 24
Denver 23
Johannesburg 23
Phoenix 23
Amsterdam 22
Ancona 22
Poplar 21
San Francisco 21
Brussels 19
Viterbo 19
Brno 18
Norwalk 18
Da Nang 17
Lanciano 17
Lappeenranta 17
Vienna 17
Boston 16
Shenyang 16
Manchester 15
Haiphong 13
Messina 13
St Louis 13
Edinburgh 12
Ankara 11
Cambridge 11
Casablanca 11
Chennai 11
Nanchang 11
New Delhi 11
Pune 11
Romola 11
Shanghai 11
Tianjin 11
Turku 11
Belo Horizonte 10
Brasília 10
Jinan 10
Mumbai 10
Quito 10
Seoul 10
Turin 10
Baghdad 9
Curitiba 9
Kunming 9
Piacenza 9
Totale 10.045
Nome #
Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients 288
An exploratory gene expression study of the intestinal mucosa of patients with non-celiac wheat sensitivity 191
Cholinergic Markers and Cytokines in OSA Patients 191
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 161
Biological insight into the extracellular vesicles in women with and without gestational diabetes 152
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis 151
PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers 150
Bladder Neck Contracture After Endoscopic Surgery for Benign Prostatic Obstruction: Incidence, Treatment, and Outcomes 148
A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma 145
The Surgical Experience Influences the Safety and Efficacy of Photovaporization of Prostate with 180-W XPS GreenLight Laser: Comparison Between Novices vs Expert Surgeons Learning Curves 141
Abiraterone acetate for early stage metastatic prostate cancer: Patient selection and special considerations 141
Trifecta and pentafecta rates after robotic assisted partial nephrectomy: Comparative study of patients with renal masses <4 and ≥4 cm 140
High Neutrophil-to-lymphocyte Ratio as Prognostic Factor in Patients Affected by Upper Tract Urothelial Cancer: A Systematic Review and Meta-analysis. 139
Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies 138
The surgical experience influences the safety and efficacy of photovaporization of prostate with 180-w xps greenlight laser: Comparison between novices vs expert surgeons learning curves 136
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis 136
Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study 136
Speed rate (SR) as a new dynamic index of melanoma behavior 132
Primary Vaginal Calculus in a Woman with Disability: Case Report and Literature Review 131
Machine learning in clinical and epidemiological research: Isn't it time for biostatisticians to work on it? 128
Correlation between Choriocapillaris Density and Retinal Sensitivity in Stargardt Disease 125
A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer 125
Leydig cell tumor in a 53-year-old patient with gynecomastia and gynecodynia: A case report and literature review 125
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 123
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study 122
Magnetic resonance spectroscopic imaging 3T and prostate cancer: correlation with transperineal ultrasound guided prostate biopsy 120
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era 120
Bladder neck contracture after surgery for benign prostatic obstruction. 119
Monocenter Experience with 532 Nm-Laser Photoselective-Vaporization of the Prostate by GreenLight XPS™ Laser: Is It Really an Endourological Joker Card? 119
Radical penectomy, a compromise for life: results from the PECAD study 119
The Use of Haemostatic Agents and Sealants for the Prevention of Lymphocele After Urological Surgery: A Review of the Literature 118
The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review. 118
Management of erectile dysfunction following robot-assisted radical prostatectomy: a systematic review 117
Infective complications after retrograde intrarenal surgery: a new standardized classification system. 116
null 116
Nutrigenetic variants and response to diet/lifestyle intervention in obese subjects: a pilot study 116
Enzalutamide in patients with castration-refractory prostate cancer: Retrospective, multicenter, real life study 115
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 115
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study 114
Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging 114
Fat mass and obesity-associated (FTO) gene epigenetic modifications in gestational diabetes: new insights and possible pathophysiological connections 113
Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection 113
Persistence and adherence to androgen deprivation therapy in men with prostate cancer: an administrative database study 111
Early Adverse Impact of Transfusion after Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison from the TRITAVI Registry 110
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 110
Effects of Curcumin and Lactoferrin to Inhibit the Growth and Migration of Prostatic Cancer Cells 110
RIRS in the elderly: Is it feasible and safe? 108
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature 108
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 107
Robot-assisted laparoscopic bladder diverticulectomy and greenlight laser anatomic vaporization of the prostate 106
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study 106
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) 105
Conservative management of urinary incontinence following robot-assisted radical prostatectomy 105
Efficacy and safety of intravesical fibrin glue instillation for management of patients with refractory hemorrhagic cystitis: 12-months results. A promising therapy for hemorrhagic cystitis 105
Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study 104
Chatgpt vs traditional pedagogy: a comparative study in urological learning 103
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 102
The effect of institution teaching status on perioperative outcomes after robotic partial or radical nephrectomy 101
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy 100
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group) 100
Synergistic effects of curcumin and lactoferrin to inhibit the prostatic cancer cells growth and migration ability 99
Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature 98
Multiple chromophobe and clear cell renal cancer in a patient affected by Birt-Hogg-Dubè syndrome: a case report 98
New insight in penile cancer 97
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 97
Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma 95
GreenLight Photoselective Vaporization of the Prostate: One Laser for Different Prostate Sizes 95
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients 95
Comparison of Perioperative Outcomes between Open and Robotic Radical Cystectomy: A Population-Based Analysis 94
Conservative treatment of upper urinary tract carcinoma in patients with imperative indications 93
null 92
Current management of radiation cystitis after pelvic radiotherapy: a systematic review 92
Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages 91
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors 91
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion 90
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis 90
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis 89
Impact of Perioperative Blood Transfusions on the Outcomes of Patients Undergoing Kidney Cancer Surgery: A Systematic Review and Pooled Analysis 89
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 89
The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis 89
Effect of Obesity and Overweight Status on Complications and Survival after Minimally Invasive Kidney Surgery in Patients with Clinical T2-4 Renal Masses 89
Green Light laser enucleation of the prostate with early apical release is safe and effective: single center experience and revision of the literature 89
Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years 88
Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1-2 N0 M0 renal cell carcinoma 87
Mastering bladder paraganglioma for optimal treatment: a case report of robot-assisted surgery 86
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 86
Transurethral prostate surgery in prostate cancer patients: A population-based comparative analysis of complication and mortality rates 86
Lower Bladder Toxicity of Salvage Versus Adjuvant Modern Radiotherapy for Prostate Cancer Patients 86
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer 86
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis 86
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma 86
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals 86
Implementation and strategies to ensure adequate coordination within a Urology Department during the COVID-19 pandemic 86
Gene Expression Profiling in Coeliac Disease Confirmed the Key Role of the Immune System and Revealed a Molecular Overlap with Non-Celiac Gluten Sensitivity 85
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art 85
Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram 84
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 84
Retzius-Sparing Robotic-Assisted Prostatectomy: Technical Challenges for Surgeons and Key Prospective Refinements 83
Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer 83
First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy 83
Totale 11.155
Categoria #
all - tutte 76.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 0 53
2021/2022871 17 25 25 77 64 34 13 52 116 71 69 308
2022/20232.437 252 369 129 281 165 410 135 201 265 28 125 77
2023/20241.277 69 34 107 28 82 389 257 67 14 55 19 156
2024/20253.043 187 587 355 77 87 188 176 201 361 144 383 297
2025/20266.903 492 285 781 682 742 371 1.164 488 712 692 337 157
Totale 16.329